Detected ·

Avanzanite Bioscience

——

Avanzanite Bioscience raised €32 Million Series A to expand rare disease drug access across Europe.

Website
—
LinkedIn
—
Amount
—
Stage
—
Event
Funding round
Detected
2026-04-16 18:13:18 UTC
Signal ID
218e318d-ff71-47f9-96b0-2740130bc8e7

As the API returns it

{
  "id": "218e318d-ff71-47f9-96b0-2740130bc8e7",
  "created_at": "2026-04-16T18:13:18.054474Z",
  "company_name": "Avanzanite Bioscience",
  "company_website_url": null,
  "company_linkedin_url": null,
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Avanzanite Bioscience raised €32 Million Series A to expand rare disease drug access across Europe.*"
}

Latest rounds